Adaptive Biotechnologies President and COO Julie Rubinstein reports disposal of $954,441.88 in common shares
ADPT•Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares from Nov. 4-6, 2026, and exercised options for the same number of shares at $12.14 each. She directly owned 377,802 common shares and held 58,990 options after the transactions.
1. Share transactions
Julie Rubinstein sold 35,643 Adaptive Biotechnologies common shares from Nov. 4-6, 2026, and exercised stock options for 35,643 shares at $12.14 per share over the same period. After the transactions, she directly owned 377,802 common shares and held 58,990 stock options.
